Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4

Journal of Molecular Medicine

Volumn 86, Issue 5, 2008, Pages 597-608

  Laudes, Matthias ^a   Bilkovski, Roman ^a   Oberhauser, Frank ^a   Droste, Andrea ^a   Gomolka, Matthias ^a   Leeser, Uschi ^a   Udelhoven, Michael ^a   Krone, Wilhelm ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adipogenesis; Dual regulator; Transcriptional repressor

Indexed keywords

CYCLIN A; HISTONE DEACETYLASE 1; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR FBI 1; TRANSCRIPTION FACTOR SIN3A;

ADIPOCYTE; ADIPOGENESIS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIATION; FEMALE; GENE ACTIVITY; GENE EXPRESSION PROFILING; IMMUNOPRECIPITATION; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POXVIRUS; PROADIPOCYTE; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL LINE, TUMOR; CHO CELLS; CLONE CELLS; CRICETINAE; CRICETULUS; CYCLIN A; DNA-BINDING PROTEINS; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; MITOSIS; MODELS, GENETIC; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 43049142182     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-008-0326-2     Document Type: Article

References (32)

1. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473-481
2. Tang QQ, Otto TC, Lane MD (2003) CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci U S A 100:850-855
3. Albagli-Curiel O, Dhordain P, Lantoine D, Aurade F, Quief S, Kerckaert JP, Montarras D, Pinset C (1998) Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis. Differentiation 64:33-44
4. Kumagai T, Miki T, Kikuchi M, Fukuda T, Miyasaka N, Kamiyama R, Hirosawa S (1999) The proto-oncogene Bc16 inhibits apoptotic cell death in differentiation-induced mouse myogenic cells. Oncogene 18:467-475
5. Labbaye C, Quaranta MT, Pagliuca A, Militi S, Licht JD, Testa U, Peschle C (2002) PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21:6669-6679
6. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O (1999) Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94:1987-1997
7. Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morriss-Kay G, Zelent A (1999) Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18:365-75
8. Pessler F, Pendergrast PS, Hernandez N (1997) Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17:3786-3798
9. Laudes M, Christodoulides C, Sewter C, Rochford JJ, Considine RV, Sethi JK, Vidal-Puig A, O'Rahilly S (2004) Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 279:11711-11718
10. Henglein B, Chenivesse X, Wang J, Eick D, Brechot C (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A 9:5490-5494
11. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J (2002) E2Fs regulate adipocyte differentiation. Dev Cell 3:39-49
12. Chauchereau A, Mathieu M, de Saintignon J, Ferreira R, Pritchard LL, Mishal Z, Dejean A, Harel-Bellan A (2004) HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF. Oncogene 23:8777-8784
13. Dhordain P, Lin RJ, Quief S, Lantoine D, Kerckaert JP, Evans RM, Albagli O (1998) The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 26:4645-4651
14. Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA (1998) A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A 95:3003-3007
15. Pessler F, Hernandez N (2003) Flexible DNA binding of the BTB/POZ-domain protein FBI-1. J Biol Chem 278:29327-29335
16. Suske G (1999) The Sp-family of transcription factors. Review. Gene 238:291-300
17. Lee DK, Suh D, Edenberg HJ, Hur MW (2002) POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J Biol Chem 277:26761-26768
18. David G, Alland L, Hong SH, Wong CW, DePinho RA, Dejean A (1998) Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16:2549-2556
19. Wolffe AP, Guschin D (2000) Chromatin structural features and targets that regulate transcription. Review. J Struct Biol 129:102-122
20. Fischle W, Kiermer V, Dequiedt F, Verdin E (2001) The emerging role of class II histone deacetylases. Review. Biochem Cell Biol 79:337-348
21. Hong SH, David G, Wong CW, Dejean A, Privalsky ML (1997) SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. Proc Natl Acad Sci U S A 94:9028-9033
22. Yoo EJ, Chung JJ, Choe SS, Kim KH, Kim JB (2006) Down-regulation of histone deacetylases stimulates adipocyte differentiation. J Biol Chem 281:6608-6615
23. Zhu L, Skoultchi AI (2001) Coordinating cell proliferation and differentiation. Curr Opin Genet Dev 11:91-97
24. Guo K, Wang J, Andres V, Smith RC, Walsh K (1995) MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15:3823-3829
25. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021
26. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Licht JD (1999) Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 18:925-934
27. Melnick A, Carlile G, Ahmad KF, Kiang CL, Corcoran C, Bardwell V, Prive GG, Licht JD (2002) Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol 22:1804-1818
28. Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14:2393-2409
29. Gaubatz S, Lindeman GJ, Ishida S, Jakoi L, Nevins JR, Livingston DM, Rempel RE (2000) E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell 3:729-735
30. Schubot FD, Tropea JE, Waugh DS (2006) Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 351:1-6
31. Stogios PJ, Chen L, Prive GG (2007) Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator. Protein Sci 16:336-342
32. Liu CJ, Prazak L, Fajardo M, Yu S, Tyagi N, Di Cesare PE (2004) Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem 279:47081-47091